Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- M00858 - Provider product page
- Provider
- Boster Biological Technology
- Product name
- Anti-BMP7 Rabbit Monoclonal Antibody
- Antibody type
- Monoclonal
- Description
- Monoclonal antibody for BMP-7/BMP7 detection. Host: Rabbit.Size: 100ug/vial. Tested applications: IP, WB. Reactive species: Human, Mouse, Rat BMP-7/BMP7 information: Molecular Weight: 49313 MW; Subcellular Localization: Secreted; Tissue Specificity: Expressed in the kidney and bladder. Lower levels seen in the brain.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Antibody clone number
- AABH-2
- Vial size
- 100ug/vial
- Concentration
- 0.5-1mg/ml, actual concentration vary by lot. Use suggested dilution ratio to decide dilution procedure.
- Storage
- At -20°C for one year. Avoid repeated freezing and thawing.
Submitted references Bone morphogenetic protein-7 inhibits endothelial-mesenchymal transition in pulmonary artery endothelial cell under hypoxia.
Effects of Panax notoginoside on the nephropathy in rats with type 1 diabetes mellitus.
Podocyte injury is suppressed by 1,25-dihydroxyvitamin D via modulation of transforming growth factor-beta 1/bone morphogenetic protein-7 signalling in puromycin aminonucleoside nephropathy rats.
Zhang H, Liu Y, Yan L, Du W, Zhang X, Zhang M, Chen H, Zhang Y, Zhou J, Sun H, Zhu D
Journal of cellular physiology 2018 May;233(5):4077-4090
Journal of cellular physiology 2018 May;233(5):4077-4090
Effects of Panax notoginoside on the nephropathy in rats with type 1 diabetes mellitus.
Tu QN, Dong H, Lu FE
Chinese journal of integrative medicine 2011 Aug;17(8):612-5
Chinese journal of integrative medicine 2011 Aug;17(8):612-5
Podocyte injury is suppressed by 1,25-dihydroxyvitamin D via modulation of transforming growth factor-beta 1/bone morphogenetic protein-7 signalling in puromycin aminonucleoside nephropathy rats.
Xiao HQ, Shi W, Liu SX, Zhang B, Xu LX, Liang XL, Liang YZ
Clinical and experimental pharmacology & physiology 2009 Jul;36(7):682-9
Clinical and experimental pharmacology & physiology 2009 Jul;36(7):682-9
No comments: Submit comment
No validations: Submit validation data